Introduction Plasmapheresis and hemoperfusion are used against cytokine release
syndrome in COVID‐19. This study aims to compare their outcomes, costs, and side‐effects …

Extracorporeal Blood Purification in moderate and severe COVID-19 patients: a prospective
cohort study Page 1 Extracorporeal Blood Purification in moderate and severe COVID-19 …

Respiratory failure and systemic inflammation are paramount features of severe SARS-CoV-
2 disease (COVID-19). Extracorporeal membrane oxygenation (ECMO) therapy has a …

Abstract Introduction: Coronavirus disease 2019 (COVID-19) is characterized by
hyperinflammation and coagulopathy. Severe cases often develop respiratory distress …

Critical clinical forms of COVID-19 infection often include Acute Kidney Injury (AKI), requiring
kidney replacement therapy (KRT) in up to 20% of patients, further worsening the outcome of …

Psoriasis is a chronic inflammatory skin disease that is characterized by well-demarcated
erythematous plaques with a silver scale. Although many new and emerging therapeutic …

To the Editor—The case count of COVID-19 continues to grow since its emergence in late
December 2019, with more than 23.7 million cases globally. A variety of pharmaceutical …

Abstract Background In December 2019, pneumonia associated with a novel coronavirus
(COVID-19) was reported in Wuhan, China. Acute respiratory distress syndrome (ARDS) is …

Abstract Background Coronavirus disease‐19 (COVID‐19) ranges from asymptomatic
infection to severe cases requiring admission to the intensive care unit. Together with …